期刊文献+

中国人群肝功能检测指标全基因组关联分析研究 被引量:4

Genome-wide association study on liver function tests in Chinese
下载PDF
导出
摘要 肝功能检测(liver function test,LFTs)指标是受遗传和环境影响的复杂性状,具有个体差异性。为系统性研究中国人群全基因组范围内单核苷酸多态性(single nucleotide polymorphism,SNP)与肝功能指标之间的联系,本研究利用英国生物银行(UK Biobank)中1653名中国人的基因分型数据和表型数据为研究对象,利用PLINK软件进行全关联分析研究(genome-wide association study,GWAS),发现229个SNP与中国人群血液中的总胆红素(total bilirubin,TB)相关,27个SNP与中国人群血液中碱性磷酸酶(alkaline phosphatase,ALP)相关,36个SNP与中国人群血液中的γ-谷氨酰转肽酶(γ-glutamyl transpeptidase,GGT)相关,1个SNP与中国人群血液中的门冬氨酸氨基转移酶(aspartate transaminase,AST)相关,最显著的位点中有11个位点是新的LFTs关联位点。通过功能基因组分析,发现这些位点的临床意义(如吉尔伯特综合征),确定了候选基因(UGT1A,ABO,GGT1),为从遗传角度理解中国人群LFTs的个体差异性和肝功能指标临床精准检测提供了前期研究基础。 Liver function tests(LFTs)measure a series of complex traits that are affected by genetic and environmental factors.Previous studies demonstrated that there exist significant differences in LFTs across individuals,which may be the results of the unique genetic profile of each individual.Therefore,we performed a genome-wide association study(GWAS)to evaluate the influence of single nucleotide polymorphisms(SNPs)in LFTs and identify the significant association between genotypes and phenotypes using 1653 Chinese subjects from the UK Biobank database.We successfully identified 229 SNPs significantly associated with total bilirubin(TB)levels,27 SNPs significantly associated with alkaline phosphatase(ALP),and 36 SNPs significantly associated withγ-glutamyl transpeptidase(GGT)in serum.In addition,one SNP significantly associated with aspartate transaminase(AST)in serum was also found.Among the most significant ones,the topmost 11 SNPs were found to be associated with LFTs for the first time.Through functional genomic analysis,the clinical significance of these SNPs could be associated with diseases(e.g.Gilbert's syndrome)and the respective candidate genes(UGT1A,ABO,GGT1).This study provides a preliminary rationale for research to understand the associations of individual genetic differences and clinical liver functions in the Chinese population.
作者 孙一丹 田子钊 周伟 李沫 怀聪 贺林 秦胜营 Yidan Sun;Zizhao Tian;Wei Zhou;Mo Li;Cong Huai;Lin He;Shengying Qin(Bio-X Institute,Shanghai Jiaotong University,Shanghai 200030,China)
出处 《遗传》 CAS CSCD 北大核心 2021年第3期249-260,共12页 Hereditas(Beijing)
基金 国家自然科学基金项目(编号:81773818,82003856)资助。
关键词 肝功能检测 总胆红素 碱性磷酸酶 Γ-谷氨酰转肽酶 全基因组关联分析 Liver function tests total bilirubin alkaline phosphatase γ-glutamyl transpeptidase genome-wide association study
  • 相关文献

参考文献4

二级参考文献58

  • 1Bénichou C.Criteria of drug-induced liver disorders.Report of an international consensus meeting[J].J Hepatol,1990,11 (2):272-276.
  • 2Navarro V.Hepatic adverse event nomenclature document[EB/OL].(2006-11-17) http://www.fda.gov/cder/livertox/presentaions 2005/vic_Navarro.ppt.
  • 3舛本後 恩地森一.藁物性肝障害の诊断.肝胆胰,2000,40:887-897.
  • 4Danan G.Causality assessment of drug-induced liver injury[J].J Hepatol,1988,7(1):132-136.
  • 5Danan G,Benichou C.Causality assessment of adverse reactions to drugs-I.A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries[J].J Clin Epidemiol,1993,46(11):1323-1330.
  • 6Maria VA,Victorino RM.Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis[J].Hepatoiogy,1997,26(3):664-669.
  • 7Lucena MI,Camargo R,Andrade RJ,et al.Comparison of two clinical scales for causality assessment in hepatotoxicity[J].Hepatology,2001,33(1):123-130.
  • 8滝川一,恩地森一,高森赖雪,他.DDW-J2004 ヮ-クショップ药物性肝障害诊断基准の提案[J].肝臓,2005,46(2):85-90.
  • 9García-Cortés M,Lucena MI,Pachkoria K,et al.Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury[J].Aliment Pharmacol Ther,2008,27(9):780-789.
  • 10Navarro VJ,Senior JR.Drug-related hepatotoxicity[J].N Engl J Med,2006,354(7):731-739.

共引文献256

同被引文献29

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部